Related Experiment Videos
[Involvement of the polypeptide system and ACE in Crohn disease]
Minerva Medica
|June 30, 1987
Summary
Serum Angiotensin Converting Enzyme (ACE) levels are elevated in active Crohn's disease, suggesting its utility in diagnosis and monitoring treatment effectiveness, particularly with steroids.
Area of Science:
- Biochemistry
- Immunology
- Gastroenterology
Context:
- Crohn's disease is a chronic inflammatory condition.
- The polypeptidyc system and its role in granulomatous diseases are not fully understood.
- Angiotensin Converting Enzyme (ACE) is a key component of the polypeptidyc system.
Purpose:
- To investigate serum ACE concentrations in patients with Crohn's disease.
- To explore the relationship between ACE levels and disease activity.
- To assess the potential of ACE as a biomarker for Crohn's disease.
Summary:
- Serum ACE levels were significantly increased in patients with active Crohn's disease.
- In stabilized phases of Crohn's disease, ACE levels were lower than in controls.
- These findings support the hypothesis that Crohn's disease, like sarcoidosis, involves the polypeptidyc system.
Impact:
- ACE levels may aid in the diagnosis and prognosis of Crohn's disease.
- Monitoring ACE levels could be valuable for tracking disease progression and treatment response.
- This research highlights the potential role of ACE in managing Crohn's disease, especially concerning steroid therapy.